55
56
Growth Score 55 in past quarter
-19 pts
Heat Score 56 in past quarter
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
592591
BioSyent is a pharmaceutical company.
- René C. Goehrum: Chairman, President & Chief Executive Officer
About the Company
BioSyent is one of Canada’s fastest growing independent pharmaceutical companies registering a compound annual growth rate (CAGR) in sales of 56% during the three year period ending 2014. It is focused on commercializing products that provide a distinguishable benefit to patients and their healthcare providers and is known for its ability to
effectively and efficiently introduce new products to the Canadian market. BioSyent is actively sought out as the Canadian market partner of choice by brand innovators with niche or specialty products looking for a trusted partner.